Simpler Grants.gov #PAR-26-058

NIH Forecast: IGNITE Grants for Assay Development and Therapeutic Agent Identification

This forecasted grant opportunity from the National Institutes of Health (NIH) supports early-stage translational research for neurological disorders: - Government Buyer: - National Institutes of Health (NIH) - National Institute of Neurological Disorders and Stroke - National Institute of Aging - NIH Helping to End Addiction Long Term (HEAL) initiative - Products/Services Requested: - Development of in vitro, ex vivo, or in vivo assays - Screening and identification of potential therapeutic agents (small molecules, biologics) - Focus on non-opioid analgesic therapeutics with minimal addiction liability - Notable Requirements: - No specific OEMs, vendors, or part numbers specified (research grant) - Broad eligibility: government, nonprofits, businesses, educational institutions, foreign organizations - Presolicitation notice to allow time for collaboration and project planning - No products or services are being directly procured; this is a grant for research and development activities

Description

The National Institutes of Health seek to support applications to develop assays and conduct screening efforts aimed at identifying and characterizing potential therapeutic agents for neurological disorders or diseases. The focus includes small molecules and biologics, with an emphasis on non-opioid analgesic therapeutics with little or no addiction liability. Applications are not currently being solicited; this notice allows potential applicants time to develop collaborations and responsive projects. Eligible applicants include various government entities, businesses, nonprofits, and educational institutions.

View original listing